TickerFacts.

Oragenics Inc (OGEN): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$20.88M
Year ended 2023-12-31
2010-12-31: -$7.86M2011-12-31: -$7.27M2012-12-31: -$12.36M2013-12-31: -$16.13M2014-12-31: -$5.79M2015-12-31: -$11.71M2016-12-31: -$8.47M2017-12-31: -$6.65M2018-12-31: -$9.96M2019-12-31: -$15.81M2020-12-31: -$26.59M2021-12-31: -$15.73M2022-12-31: -$14.38M2023-12-31: -$20.88M-$20.88M
2010-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$20.88Mn/m2025-03-14, From 2023-01-01
2022-12-31-$14.38Mn/m2024-03-29, From 2022-01-01
2021-12-31-$15.73Mn/m2023-04-17, From 2021-01-01
2020-12-31-$26.59Mn/m2022-07-29, From 2020-01-01
2019-12-31-$15.81Mn/m2021-03-01, From 2019-01-01
2018-12-31-$9.96Mn/m2020-03-04, From 2018-01-01
2017-12-31-$6.65Mn/m2019-03-29, From 2017-01-01
2016-12-31-$8.47Mn/m2018-02-16, From 2016-01-01
2015-12-31-$11.71Mn/c2017-02-27, From 2015-01-01
2014-12-31-$5.79Mn/m2016-03-30, From 2014-01-01
2013-12-31-$16.13Mn/m2015-02-27, From 2013-01-01
2012-12-31-$12.36Mn/m2014-02-28, From 2012-01-01
2011-12-31-$7.27Mn/m2013-03-26, From 2011-01-01
2010-12-31-$7.86Mn/a2012-04-16, From 2010-01-01